Precision BioSciences Announces that the US Patent Office Rejects All Claims to Cellectis Patent

Precision BioSciences, Inc., a leader in the field of genome engineering, today announced that the United States Patent and Trademark Office has issued a first, non-final Office Action in the reexamination proceedings for U.S.

Elliott Levinthal, Stanford professor emeritus of mechanical engineering, dead at 89

In a career that ranged from radar to medicine to outer space, Elliott Levinthal played an instrumental role in the schools of Engineering and Medicine, and in the rise of Silicon Valley.

Genome engineering firm Precision BioSciences gets patent victory

North Carolina biotechnology company Precision BioSciences has secured a patent victory for its genome engineering technology. The U.S. Patent and Trademark Office has rejected claims from French company Cellectis that alleges that Precision is infringing on a Cellectis patent. The USPTO decision rejects Cellectis’ claims as being anticipated by or obvious in the context of already [...]

Press Release

Precision BioSciences Inc. Posted on:23 Jan 12 Precision BioSciences, Inc., a leader in the field of genome engineering, today announced that the United States Patent and Trademark Office (PTO) has issued a first, non-final Office Action in the reexamination proceedings for U.S. Pat. No. 7,897,372 (“the ‘372 patent�) that is owned by Cellectis SA. Importantly, this Office Action rejected ...

VU office helps turn ideas into products

As assistant vice chancellor of technology transfer and intellectual property development, Alan Bentley has spent the past six months overseeing expansion of Vanderbilt University's push to commercialize research and turn discoveries into products.